Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin

Keyphrases

• Human Skin 100%
• Malignant Melanoma 100%
• Dysplastic Nevus 100%
• Primary Cutaneous Melanoma 100%
• Immune Signature 100%
• Melanocytic Nevus 50%
• T Helper 1 33%
• Tolerogenic Dendritic Cells 33%
• Quantitative PCR 16%
• Molecular Markers 16%
• Differential Expression 16%
• Melanoma 16%
• Regulatory T Cells 16%
• Gene Signature 16%
• Gene Expression Analysis 16%
• Neoplastic Cells 16%
• Immune Activation 16%
• Molecular Gene 16%
• Gene Expression Profiling 16%
• False Discovery Rate 16%
• Dendritic Cells 16%
• Immune Regulation 16%
• Interleukin-12 (IL-12) 16%
• Cell-Associated 16%
• Unique Genes 16%
• Immune Parameters 16%
• Benign Lesion 16%
• Melanoma Progression 16%
• Immunosuppressive Microenvironment 16%
• Atypical Features 16%
• Suppressor of Cytokine Signaling 3 (SOCS3) 16%
• Cytotoxic T Cell Response 16%
• Melanomagenesis 16%
• Exhausted T Cells 16%
• Change Discovery 16%
• Suppressive Immune Cells 16%

Medicine and Dentistry

• Nodular Melanoma 100%
• Cutaneous Melanoma 100%
• Dysplastic Nevus Syndrome 100%
• Dendritic Cell 37%
• Melanocytic Nevus 37%
• Gene Expression Profiling 25%
• Cytotoxic T-Cell 12%
• Reverse Transcription Polymerase Chain Reaction 12%
• T Cell 12%
• Immunotherapy 12%
• Immunocompetent Cell 12%
• Molecular Marker 12%
• Immunosuppressive Drug 12%
• T-Cell Response 12%
• Regulatory T Cell 12%
• Suppressor of Cytokine Signaling 3 12%